Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Palisade Bio presented a poster titled "PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug, Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS Mouse Model” at the Crohn's & Colitis Congress ...
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...
Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).
A groundbreaking test can now predict colorectal cancer risk in IBD patients with over 90 accuracy offering a less invasive ...
Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...
Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...
A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as ...
Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...
“Most people with ulcerative colitis or Crohn’s disease won’t develop bowel cancer. “But for those that have these conditions and are showing signs of pre-cancer in their colon, there are some tough ...
"Most people with ulcerative colitis or Crohn's disease won't develop bowel cancer. "But for those that have these conditions ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results